Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene

Blue washed image of scientist looking at test tube

Join a 30-minute webinar that transforms your understanding of today’s vaccine development. The webinar features presentations from Dennis Christensen, PhD – Head of R&D Adjuvant Systems, and Rebecca Wood - Life Sciences Sustainability Manager. The webinar will feature the science behind Croda Pharma’s latest innovation in Sustainable Squalene, an essential excipient in vaccine adjuvant systems. You will learn how this groundbreaking innovation not only reduces environmental impact but also helps deliver high-quality squalene for a range of vaccines that target diseases like influenza, tuberculosis, shingles, schistosomiasis, HIV, and more.

What you will learn:

Why adjuvants matter: Explore how adjuvants enhance vaccine efficacy, with a special focus on squalene's established advantages.
Sustainable solutions: Discover how Croda achieves secure and scalable supply chains through shark-free sourcing methods while minimising the product's carbon footprint.
Quality & consistency: Stringent manufacturing processes combined with stability data provide essential assurance for both vaccine purity and reliability.
Beyond influenza: Explore future clinical development pathways for the most critical disease areas.

This session has been designed for vaccine R&D professionals and manufacturers along with academic researchers. Attend to receive exclusive content and a sneak peek of our behind-the-scenes documentary filmed at the purification manufacturing site in Leek, United Kingdom. Secure your spot now to see how Croda Pharma’s Sustainable Squalene can accelerate the future of vaccine innovation.

Dr. Christensen was appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery systems. In this period, he has played a key role in the development of the CAF^®adjuvant portfolio. His recent research includes designing vaccines that target specific subsets of APCs and direction of vaccine-induced immune responses to specific tissues. He is a key opinion leader in the vaccine adjuvant research field and has an extensive experience with international vaccine research collaborations and with coordinating the research work in such projects.

Rebecca joined Croda in September 2015 with a background in chemistry, sustainability and collaboration. Rebecca is responsible for developing and executing the sustainability strategy across Croda Pharma and Croda Agriculture, focusing on aligning priorities and progress with our customers' sustainability needs. Rebecca has over 15 years of experience utilising sustainable design principles, life cycle analysis, and carbon footprinting, with a particular focus on renewably derived raw materials and biocatalysis. More recently, Rebecca also assumed responsibility for developing Croda’s Net Zero roadmap, focusing on product-specific approaches that translate into customer benefits.

Title:Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene

Date:15/04/25, 9:00 CEST

Duration:30 minutes

Available On Demand

To register, please fill in the form below

indicates required field

First name

Please provide your first name

Last name

Please provide your last name

Please provide an email address

Unfortunately, you are not able to register with that email address. Please get in touch using our contact form and one of our team will assist you.

Company

Please provide your company name

Job title

Department

Country

County/Region

Phone

Please provide a valid phone

I have read and understood Croda’s privacy policy

Please confirm you have read and understood Croda’s privacy policy

Would you like to receive updates on our products, events and other marketing communications from Croda?

Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene

Speakers

Thank you for registering for Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene